Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kofu
Clinical trial register · Japan

Clinical Trials in Kofu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Kofu

15 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Regeneron Pharmaceuticals
Phase 3
270
Nagoya, Okayama, Tokushima, Kofu, Matsumoto-shi
2026-05-21
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Nagoya, Urayasu, Shinjuku Ku, Kofu, Niigata
2026-03-09
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Bunkyō City, Chiba, Kamakura-shi, Kamogawa, Kofu, Minato, Shibuya City, Yokohama
2026-02-04
Recruiting
Eli Lilly and Company
Phase 3
150
Abeno, Iruma, Kawasaki, Kofu, Kōriyama, Kumamoto, Nagano, Naka
2026-01-12
Recruiting
Eli Lilly and Company
Phase 3
7,140
Chūōku, Hamadayama, Suginami-ku, Izumisano, Kobe, Kofu, Kumamoto, Shinjuku-ku, Takarazuka
2025-12-01
Recruiting
Pfizer
Phase 3
6,000
Kurume, Sendai, Beppu-shi, Habikino, Izumisano, Kofu, Fukui, Kyoto
2025-08-25
Recruiting
Sanofi
Phase 3
90
Nagoya, Tsuchiura, Kanazawa, Fujisawa, Suita, Iruma, Kofu, Fukuoka
2025-08-18
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Asahikawa, Bunkyō, Chikushino-shi, Kashiwa-shi, Kobe, Kofu, Nagasaki, Nara
2024-07-18
Active, closed
AbbVie
Phase 3
184
Ichinomiya, Marugame, Kyoto, Kurashiki, Mibu, Suginami-Ku, Tachikawa-shi, Kofu
2024-06-14
Active, closed
Pfizer
Phase 3
394
Nagoya, Sendai, Sakai, Bunkyo-ku, Shinjuku-ku, Kofu
2024-01-19
Active, closed
AbbVie
Phase 3
614
Nagoya, Sakai-shi, Suita-shi, Bunkyo-ku, Shinjuku-ku, Yamagata, Kofu
2023-12-19
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Nagoya, Osaka, Suita, Kofu, Kumamoto
2023-02-02
Active, closed
Janssen Research & Development, LLC
Phase 1/2
235
Fukuoka, Kofu, Osaka, Toyama
2022-04-11
Recruiting
Eisai Co., Ltd.
Phase 1
18
Hakata, Kurume, Yuhu, Bukyo-ku, Mintato-ku, Shinjuku-ku, Kofu, Kyoto
2020-02-27
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Fukushima, Iruma-gun, Kanagawa, Kitakyusyu-Shi, Kofu, Ōgaki, Sapporo, Sendai
2019-08-15
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-japan/city/kofu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Kofu.

How many clinical trials are recruiting in Kofu?

9 of the 15 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kofu), 15 studies
PhaseStudiesRecruitingShare
Phase 310666.7%
Phase 22213.3%
Phase 1116.7%
Phase 1/2106.7%
Phase 2/3106.7%

Most active sponsors

Lead sponsors with the most studies (Kofu)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC31
AbbVie20
Eli Lilly and Company22
Novartis Pharmaceuticals21
Pfizer21
Eisai Co., Ltd.11
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)11
Regeneron Pharmaceuticals11
Sanofi11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.